Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to assess the feasibility and safety of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. The clinical data may be used to support subsequent regulatory applications and further evaluation of the Supira System.


Clinical Trial Description

The Supira System is a temporary (≤ 4 hours) ventricular support device indicated for use during elective or urgent high-risk percutaneous coronary interventions (HRPCI) performed in hemodynamically stable patients with severe coronary artery disease when a heart team, including a cardiac surgeon, has determined HRPCI is the appropriate therapeutic option. Use of the Supira System in these patients may prevent hemodynamic instability which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri- and postprocedural adverse events ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06087575
Study type Interventional
Source Supira Medical
Contact
Status Not yet recruiting
Phase N/A
Start date January 2024
Completion date August 2024

See also
  Status Clinical Trial Phase
Completed NCT05612555 - Low Psoas Index and Cardiac Assistance: No Excess Mortality at D28 Post Implantation
Completed NCT04526964 - Improved Self-management for Patients on Ventricular Assist Device (VAD) Support - Phase 3 N/A
Completed NCT04234230 - Improved Self-management for Patients on Ventricular Assist Device (VAD)
Completed NCT03843021 - Ventricular Assist Device (VAD) Infection Prevention Survey
Recruiting NCT04613401 - Influence of Telemonitoring on the Management of LVAD-patients